Ginger (fresh or tea) reduces nausea
News provided by Ro Apr 02, 2026, 13:02 ET The most effective GLP-1 medication is now available in a multi-dose pen NEW YORK, April 2, 2026 /PRNewswire/ -- Ro, the leading direct-to-patient healthcare company, today announced that it is working with Eli Lilly to launch the recently FDA-approved Zepbound (tirzepatide) KwikPen nationwide on its platform
Understanding the Market Shake-Up and What It Means for Private Practices In a move that sent ripples across the pharmaceutical and medical community, Novo Nordisk has announced that CEO Lars Fruergaard Jrgensen will step down after 34 years, citing market challenges and a 53% drop in share price
Preclinical studies in animal models have demonstrated that survodutide effectively activates both GLP-1R and GCGR, resulting in reduced body weight, slower gastric emptying, decreased energy intake, increased energy expenditure, and improved glucose tolerance [86]